Zacks.com on MSN7h
Eli Lilly (LLY) Vs Novo Nordisk (NVO): Which is the Best Weight Loss Stock for 2025?Weight loss goals may be at the forefront of many New Year's resolutions, which could push the exuberance for Eli Lilly LLY ...
Britain's Terry Smith made public for the first time why Fundsmith Equity Fund dumped its Diageo stake last year.
The UK's self-regulated system for disclosing payments from drug companies to healthcare professionals and organizations is ...
The award was launched last year and comes with a NOK 200,000 (€17,000) cash prize. The jury for the Nordic Series Script ...
GlobalData on MSN21h
Novo Nordisk and Valo expand cardiometabolic drug partnershipNovo Nordisk has expanded its partnership with Valo Health to advance new therapies for type 2 diabetes, obesity and ...
Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug ...
Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed German drug ...
According to DelveInsight's analysis, the mild cognitive impairment market is anticipated to increase during the forecast period (2024-2034), owing to the rise in the launch of emerging therapies ...
1d
DelveInsight's Mild Cognitive Impairment Market Insights report includes a comprehensive understanding of current treatment ...
Limited ("BBI"), global leader in the development and manufacture of IVD reagents, announces a CEO succession. After 7 years ...
Braman Motors' lawyers believe their client is the first ERISA plan sponsor to join a big group of plaintiffs with cases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback